Vitamin A Regulates Th1/Th2 Development via RXR Pathway

+描述（由申请人提供）：饮食影响先天性和适应性免疫功能，因此可以影响对感染性和炎性疾病的抵抗力和恢复。我们的长期目标是确定维生素A如何调节T细胞介导的免疫反应。维生素A缺乏会增加儿童常见感染的死亡率，并损害辅助性T细胞2型（Th 2）促进的免疫反应。这些反应包括血清IgG 1和IgE反应、分泌型伊加反应和嗜酸性粒细胞介导的炎症反应，例如在肠道蠕虫感染和过敏反应（包括哮喘）期间发生的炎症反应。维生素A调节Th 2应答的分子机制尚不清楚。我们最近发现，刺激抗原初始Th 0细胞中的类维生素A X受体（RXR）通路促进Th 2记忆细胞的发育（如IL-4的产生所示），而刺激视黄酸受体（RAR）通路则不会。我们建议，RXR介导的特定基因的转录是正常的Th 2发展所必需的。在本申请中，我们建议使用体外研究来鉴定这些基因，并确定RXR是单独作用还是与伴侣受体一起作用。RXR或伴侣受体配体调节表达的机制（即，通过与转录复合物的DNA应答元件或其它蛋白质组分相互作用）。然后，我们将使用受体选择性类维生素A和RXR基因敲除小鼠，以确定在体内，如果RXR调节Th 2细胞的发展和Th 2介导的抗体反应。确定维生素A调节Th 2介导的免疫和炎症反应的机制将在几个方面有用。它将有助于评估使用维生素A（以及可能与RXR伴侣受体结合的营养素，如维生素D和脂肪酸）的临床和公共卫生干预措施，以降低缺乏人群的发病率和死亡率。了解这些相同的机制也将有助于我们确定美国人群营养摄入的安全上限，其中慢性炎症（由Th 2和Th 1细胞介导）非常普遍。最后，这项工作可能会提出新的干预策略，以调节慢性炎症条件。此外，受体选择性类维生素A目前用于癌症治疗，并正在评估糖尿病。这项工作将有助于评估这些疗法可能产生的副作用。

+DESCRIPTION (provided by applicant): Diet affects both innate and adaptive immune function and thus can influence resistance to and recovery from infectious and inflammatory diseases. Our long-term objective is to define how vitamin A regulates T-cell mediated immune responses. Vitamin A deficiency increases mortality from common childhood infections and impairs immune responses promoted by T-helper type 2 (Th2) cells. These responses include the serum IgG1 and IgE responses, the secretory IgA response, and eosinophil-mediated inflammatory responses, such as occur during gut helminth infections and allergic responses, including asthma. The molecular mechanisms by which vitamin A modulates Th2 responses are not known. We have recently found that stimulation of the retinoid X receptor (RXR) pathway in antigen-naive Th0 cells promotes development of Th2 memory cells (as indicated by the production of IL-4), while stimulation of the retinoic acid receptor (RAR) pathway does not. We propose that RXR-mediated transcription from specific genes is required for normal Th2 development. In this application we propose to identify these genes - using in vitro studies - and determine if RXR is acting alone or together with a partner receptor. The mechanism(s) by which RXR or partner receptor ligands regulate expression (i.e., by interacting with DNA response elements or other protein components of the transcription complex) will be identified. We will then use receptor-selective retinoids and RXR-knockout mice to determine, in vivo, if RXR regulates Th2 cell development and Th2-mediated antibody responses. Identifying the mechanisms by which vitamin A modulates Th2-mediated immune and inflammatory responses will be useful in several ways. It will help in evaluating clinical and public health interventions using vitamin A (and, perhaps, nutrients that bind to RXR partner receptors, such as vitamin D and fatty acids) to decrease morbidity and mortality in deficient populations. Understanding these same mechanisms will also help us determine safe upper limits for nutrient intake in the U.S. population, where chronic inflammatory conditions (mediated by both Th2 and Th1 cells) are highly prevalent. Finally, this work may suggest novel intervention strategies to modulate chronic inflammatory conditions. In addition, receptor-selective retinoids are currently used in cancer therapy and are being evaluated for diabetes. This work will help evaluate possible side effects of these therapies.